Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Features

656 Features
Pharma ‘HTS’ the Mark with Screening

22 Jul 10

Back in May, it was announced that new stem cell research would reduce the need for animal testing. Now, we are really beginning to see the benefits of groundbreaking science that is not reliant on out dated methods of testing.
Emma Naylor

Increasing numbers of deaths from malignant melanoma should be prevented by early detection and protection from ultraviolet rays

20 Jul 10

Skin cancers come in various forms but the type which causes most fear is the malignant melanoma, derived from the pigment-forming cells of the skin or melanocytes.
Dr Laurence Lever

The Research Revolution

19 Jul 10

During a time of major economic downturn, there are few industries that can be said to be truly ‘recession proof’. Yet for years now, big pharma has largely been seen as precisely that. After all, no matter dire the markets, and no matter how low consumer confidence plummets, there is always a demand for healthcare.
Max Golby

NHS Targets

25 Jun 10

In areas such as competition policy and choice in the NHS, there could be said to be much correlation between the approaches of both governments past and present. Yet in other key areas of policy, there are unquestionably examples of ideological, or at least philosophical, differences in outlook. Or at least in theory.
Max Golby

Swine Flu Hoax

18 Jun 10

A selective memory is a wonderful thing. That is, if you're a conspiracy theorist or an opportunistic critic of any kind. Yet, for those of us with memories of a more consistent mold, a lot of the current and decidedly harsh criticism directed against the World Health Organization’s handling of the just passed H1N1 'Swine Flu' outbreak must be questioned in kind.
Max Golby

Competition in the Health Service

17 Jun 10

As the new Conservative-led coalition finally begins to settle down to the task ahead, questions of policy detail are increasingly replacing the brouhaha of election-time buccaneering and healthcare policy and the NHS are no exceptions to the rule – particularly in the case of competition policy.
Max Golby

A Very Human Response to the Recession

28 May 10

With every challenge comes a new opportunity. Indeed, if we are to believe the results of a recent international workforce survey by Kelly Services, while the global economic recession has produced troubles a plenty, it has also evoked a new found sense of entrepreneurialism as workers look to adjust to changing employment models and to respond to new challenges in a very human way.
Max Golby

Astellas Pharma five year anniversary: Past success, future thinking

28 May 10

Just five years after its formation through the merger of Fujisawa and Yamanouchi, Astellas has become one of the top 20 pharmaceutical companies in the world. Employing 15,000 people and with annual sales reaching €1,287 million in Europe, Astellas has exceeded all expectations for growth in the past five years and the company’s management team has devised a clear vision to ensure that this success continues in the years to come.
Astellas Pharma

New wave of independent, self-employed free agents emerging around the world, Kelly® international workforce survey finds

20 May 10

Economic uncertainty has fueled a growing trend toward self-employment and entrepreneurialism with one-in-five respondents worldwide now working outside the traditional employment relationship, and 50 percent saying that they would like to do so, according to the latest survey results from workforce solutions leader Kelly Services®.
Editor

National Stop Snoring Week 19-24 April

23 Apr 10

The theme for National Stop Snoring Week 2010 is all about our houses. From house dust mites to pet dogs it seems that our houses are minefields when it comes to snoring. Nobody is safe as there are dangers lurking in every room.
Marianne Davey - The British Snoring & Sleep Apnoea Association (BSSAA)

Karolinska Institutet report findings - Personalised Medicine and future healthcare delivery

22 Apr 10

Karolinska Institutet is one of the world´s leading medical universities. Its mission is to contribute to the improvement of human health through research and education. Karolinska Institutet accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country´s broadest range of education in medicine and health sciences. Since 1901 the Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.
Alex Heeley - De Facto Communications

Allergy relief for babies and young children

14 Apr 10

Parents of babies and young children suffering from conditions such as asthma and eczema will be relieved to know there is a breakthrough product available that can drastically reduce their child’s misery and symptoms.
Kaleidoscope Communications

Fighting talk unites Pharma

13 Apr 10

The NGP union, held in the Netherlands last week saw over 50 visionaries gathered for the Supreme Court verdict against Myriad Genetics given on March 29th. They voted against their patent claims and a storm is brewing in the biotech community. The Court ruled that the patents should have never been granted because genes are a law of nature. With the majority of industry outsiders in agreement, how will the pharmaceutical world react?
ngonlinenews.com

Homeopathy and the NHS

13 Apr 10

Since the moment of the NHS’s very inception in 1948, complementary medicine has formed an accepted and often-used element of the country’s national health service. Thousands of Brits swear blind by the efficacy of homeopathic treatments and rates of patient satisfaction are often far higher at the country’s homeopathic hospitals than they are on standard NHS wards. Yet while many patients claim a strong appreciation of the benefits of homeopathy, the science tells another story.
Max Golby

Shaping the market

09 Apr 10

Until recently, pharmaceutical companies paid little attention to the process of maximising their data through publications. Today, several pharma firm and even consumer companies are beginning to recognise publications planning as an integral part of the marketing matrix. It now forms part of the overall communications strategy, adopted not only to raise awareness of a product and its key messages, but also to provide an evidence base for all other communication activities for the product.
Dr Sabah Al-Lawati

Patient Advice in the Digital Age

07 Apr 10

We often use them to make decisions about what products we buy and which we keep buying…except for pharma’. Yet more than that, he makes a coherent and convincing argument for how these kinds of services could ultimately end up benefiting the pharma industry itself. Indeed while information from a single person on the internet might be far too subjective to be of use, the sophistication of the crowd is arguably much greater.
Max Golby

Pharma Research Cuts

17 Feb 10

Research and development is the bread and butter of healthcare innovation. For decades the world’s pharmaceutical companies have treasured and protected this simple maxim, pouring billions of dollars into research and development and creating hundreds of groundbreaking new drugs in the process. Yet since the onset of the global financial crisis in 2007, big pharma has begun to ask some very difficult questions of its research commitments.
Max Golby

Diabetes – an Overview

10 Feb 10

Diabetes mellitus – more commonly known as just diabetes – is a chronic metabolic condition that occurs as a result of either the pancreas’ failure to produce normal insulin levels, or as a result of the body’s inability to make use of the insulin that it does produce.
Max Golby

A Kidney Research UK study has proved that the Renal Services National Service Framework has had a positive impact in improving quality of care for the high-risk South Asian communities.

10 Feb 10

A recent research study, which was undertaken as part of medical research charity, Kidney Research UK’s ABLE programme, investigated the impact of national guidelines for the management of Chronic Kidney Disease (CKD), on referral patterns between South Asian and white European patients with type 2 diabetes mellitus (T2DM).
Kidney Research UK

How to | Use RSS to get a pharma job

27 Jan 10

RSS is a much under-estimated and under-used thing. It was originally conceived as an easy way of syndicating website content, hence the name “Really Simple Syndication”, but it now become a standard by which content is made available across the web to other sites or users.
Mike Wood

Haiti Aid

27 Jan 10

At 16:53 local time on Tuesday, 12 January 2010, the small Caribbean island nation of Haiti was dealt another cruel blow: a massive 7.0-magnitude earthquake struck at the heart of the nation - just over 15 miles west of the capital of Port-au-Prince. With the already traumatic history of this poor yet historic nation in mind, the events of January 12 represented yet another devastating hit to the already fragile foundations of this young nation.
Max Golby

Alzheimer’s - An Overview

21 Jan 10

Hardly a week goes by without Alzheimer’s being in the news – scientists discovering more about what causes it, developing a greater idea of how we can prevent or treat it, or another step being taken towards a cure.
Jackie Cosh, author of Alzheimer’s – The Essential Guide

Paying Off Competitors

14 Jan 10

Washington is famous for its lobbyists. Make no mistake, of all the industries currently making themselves heard on Capitol Hill, the healthcare lobby is one of the largest and the loudest. Indeed, according to the Center for Responsive Politics, the pharmaceutical industry had almost 1700 registered lobbyists in Washington as of late 2009. Unsurprisingly, then, the pharmaceutical industry has a considerable degree of pull on The Hill.
Max Golby

Gearing Up In 2010

23 Dec 09

This is the second of two articles written by Caroline Lock and Spencer Marsh at Only Medics Recruitment Ltd. In the last edition they looked at Recruitment 2010 and in this article they discuss Career Planning 2010.
Stephen Smith

Healthcare Reform

16 Dec 09

For over 75 years now, numerous Democratic Congressmen – and indeed several Presidents – have tried to pass something remotely resembling meaningful healthcare reform. For 75 years, they have failed. Back in 1993, Bill and Hillary Clinton’s failed ‘HillaryCare’ died with a whimper in the Senate and Mrs. Clinton was denied her chance at a second attempt by Mr. Obama in the Democratic primaries.
Max Golby

How to get experience and make the most of it.

08 Dec 09

‘You really need some more experience’. Perhaps the most ubiquitous phrase in modern day recruitment, thousands of graduates are now at the mercy of this one requirement as increasing competition in the job market leads to rising standards. Perhaps twenty, or even ten years ago, an undergraduate degree and a forceful sense of charisma might well have been enough to net you your first role in an industry.
Max Golby

ORBIS: what is it and how does it work?

08 Dec 09

Keynes called it an ‘inducement to invest’. In this instance, the most recent financial crisis has called for many of the same approaches used in the 1930s to stimulate the economy and bring industries back to their feet. Today more than ever, we realize that education is one of the most decisive facets of any successful stimulus.
Max Golby

USA, payments to Doctors – good, bad or ugly

08 Dec 09

At what point does a conflict of interests occur? Last year – and for many years before that – U.S. drugs companies paid out tens of millions of dollars in payments and gifts to physicians and academics. Earlier this year, the Pharmaceutical and Research Manufacturers of America (PhRMA) released a revised, and somewhat toughened, code of practice.
Max Golby

UK Visa’s and work permits – an overview for Pharma

07 Dec 09

Over the past year or so, the system for issuing VISAs and work permits in the UK has changed dramatically. A knowledge of the practical implications of the new system will be vital for anyone hoping to bring their skills to the pharmaceutical industry in this country
Max Golby

Halycon Days.. Are they over now - CSL's Perception

02 Dec 09

The phrase Halcyon days is a literary commonplace in the English language English language and culture, signifying ideals of prosperity, bonhomie, joy, liberation, or tranquility. I can testify to experiencing all these sentiments having worked in Clinical R&D for nearing 30 years. I'm not so certain we'll ever return to the same again though.
Ann Maloney BSc FICR

Advertising